Rethinking Clinical Trials

JANUARY 15, 2025

Lindsell is professor and cochief of biostatistics and bioinformatics, director of data science and biostatistics at the Duke Clinical Research Institute, and director of biostatistics and bioinformatics at the Duke Clinical and Translational Science Instituteall at Duke University. Join the online meeting.

Bioinformatics 167

Bioinformatics Clinical Trials Clinical Trials Clinical Research 167

Rethinking Clinical Trials

FEBRUARY 21, 2024

In this Friday’s PCT Grand Rounds, Adrian Hernandez and Christopher Lindsell of Duke University will present “Virtual Vigilance: Monitoring of Decentralized Clinical Trials.” ” The Grand Rounds session will be held on Friday, February 23, 2024, at 1:00 pm eastern. Join the online meeting.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Bioinformatics 130

Rethinking Clinical Trials

FEBRUARY 19, 2024

In this Friday’s PCT Grand Rounds, Adrian Hernandez and Christopher Lindsell of Duke University will present “Virtual Vigilance: Monitoring of Decentralized Clinical Trials.” ” The Grand Rounds session will be held on Friday, February 23, 2024, at 1:00 pm eastern. Join the online meeting.

Trials 135

Trials Bioinformatics Clinical Trials Clinical Trials 135

Rethinking Clinical Trials

FEBRUARY 28, 2024

            Speakers Adrian Hernandez, MD Executive Director, Duke Clinical Research Institute Vice Dean, Duke University School of Medicine Christopher J. The global decentralized clinical trial market is expected to grow at a compound annual growth rate of 30.1% from 2021 to 2026.

Clinical Trials 111

Clinical Trials Clinical Trials Trials Clinical Research 111

XTalks

MAY 20, 2022

Doctors and physicians rely on the results provided by a clinical scientist to make an accurate prognosis, diagnosis and assessment for a patient’s treatment plan. What is it Like to Work as a Clinical Scientist? A clinical scientist is often synonymous with: Clinical Research / Clinical Laboratory Scientist.

Scientist 105

Scientist Life Science Clinical Research Doctor 105

XTalks

SEPTEMBER 5, 2023

Investigation of the possibility of VAED is crucial during clinical trials for decision-making on vaccine licensing by regulatory agencies. In the majority of cases, the risk of VAED is brought to light during preclinical stages or early clinical trial phases.

Vaccination 96

Vaccination Vaccine Development Clinical Trials 96

Worldwide Clinical Trials

APRIL 7, 2025

Solid tumors present a significant challenge to clinical research due to their complex and heterogeneous nature. Have you optimized your trial designs to employ precision medicine approaches for your novel solid tumor intervention?

Medicine 100

Medicine Research Clinical Trials Clinical Trials 100